Please login to the form below

Not currently logged in
Email:
Password:

Tretten

This page shows the latest Tretten news and features for those working in and with pharma, biotech and healthcare.

US approval for Novo's Factor XIII drug Tretten

US approval for Novo's Factor XIII drug Tretten

Study findings demonstrated that monthly treatment with Tretten prevented bleeding in 90 per cent of patients, with no evidence of abnormal clotting. ... Novo Nordisk said Tretten is expected to be launched in the US early next year.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
JPA Health Communications

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics